Your doctor might adjust your dosage, recommend additional therapies, or suggest alternative options if semaglutide isnt meeting your expectations
These effects result from the medication's action on GLP-1 receptors in the gastrointestinal tract, slowing gastric emptying and affecting gut motility
Semaglutide for the treatment of obesity: Semaglutide for obesity is a new formulation of Semaglutide that has been specifically designed to treat obesity
The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction
Our clinical trials showed remarkable benefits in weight loss, blood sugar regulation, and metabolic healthwith no traditional side effects
It was approved by the FDA in 2017 for managing type 2 diabetes, and has since gained popularity due to its weight-loss effects